Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort

Is type 2 diabetes really a coronary heart disease risk equivalent?

(2013) Christoph H. Saely et al.   VASCULAR PHARMACOLOGY

Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels

(2012) Rui-Xing Yin et al.   Cardiovascular Diabetology

Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non–high-density lipoprotein cholesterol in men

(2012) Madiha F. Abdel-Maksoud et al.   Journal of Clinical Lipidology

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels

(2011) Nicola Ferri et al.   ATHEROSCLEROSIS

PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke

(2011) Estelle Rousselet et al.   JOURNAL OF LIPID RESEARCH

The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations

(2011) Lynn Htet Htet Aung et al.   Lipids in Health and Disease

Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box

(2011) Dick C. Chan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles

(2009) Giuseppe Danilo Norata et al.   ATHEROSCLEROSIS

Longitudinal Association of PCSK9 Sequence Variations With Low-Density Lipoprotein Cholesterol Levels

(2009) Chiang-Ching Huang et al.   Circulation-Cardiovascular Genetics

PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities

(2009) Majambu Mbikay et al.   FEBS LETTERS

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease

(2009) Marianne Abifadel et al.   HUMAN MUTATION

The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis

(2009) S. A. Mousavi et al.   JOURNAL OF INTERNAL MEDICINE

Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population

(2008) Eliana Polisecki et al.   ATHEROSCLEROSIS

Molecular basis of PCSK9 function

(2008) Gilles Lambert et al.   ATHEROSCLEROSIS

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey

(2008) Bin Zhang et al.   CURRENT MEDICAL RESEARCH AND OPINION

Molecular basis for LDL receptor recognition by PCSK9

(2008) H. J. Kwon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA